✦ LIBER ✦

Consensus-Based Evaluation of Clinical Significance and Management of Anticancer Drug Interactions

✍ Scribed by Frank G.A. Jansman; An K.L. Reyners; Eric N. van Roon; Carolien H. Smorenburg; Helgi H. Helgason; Marianne le Comte; Brigit M. Wensveen; Annemieke M.A. van den Tweel; Mieke de Blois; Wilma Kwee; Adrian L. Kerremans; Jacobus R.B.J. Brouwers

Book ID: 113544341
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 307 KB
Volume: 33
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2011.01.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinically Significant Drug-Drug Interac

Clinically Significant Drug-Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug Compendia

✍ Wong, C.-M.; Ko, Y.; Chan, A. 📂 Article 📅 2008 🏛 Harvey Whitney Books Company 🌐 English ⚖ 345 KB

Clinically significant drug—drug interac

Clinically significant drug—drug interactions between oral anticancer agents and nonanticancer agents: A delphi survey of oncology pharmacists

✍ Alexandre Chan; Seow-Hwei Tan; Chen May Wong; Kevin Yi-Lwern Yap; Yu Ko 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Clinical evaluation and management of dr

Clinical evaluation and management of drug hypersensitivity

✍ Volcheck, Gerald W 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Clinical risk management of herb–drug in

Clinical risk management of herb–drug interactions

✍ Peter A. G. M. De Smet 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Drug interactions of clinical significan

Drug interactions of clinical significance to dermatologists: A primer and update

✍ James Q. Del Rosso 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 557 KB

Lack of Clinically Significant Drug Inte

Lack of Clinically Significant Drug Interactions between Nevirapine and Buprenorphine

✍ Elinore F. McCance-Katz; David E. Moody; Gene D. Morse; Qing Ma; Petrie M. Raine 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 146 KB